Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Services (Clinical Trial Design And Consultation Services, Reading And Analytical Services), By End Use, By Application, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Clinical Trial Imaging Market Growth & Trends
The global clinical trial imaging market is expected to reach USD 1.97 billion by 2030, exhibiting a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.
The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.
Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility
Clinical Trial Imaging Market Report Highlights
Clinical Trial Imaging Market Growth & Trends
The global clinical trial imaging market is expected to reach USD 1.97 billion by 2030, exhibiting a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.
The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.
Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility
Clinical Trial Imaging Market Report Highlights
- Project and Data Management Services held the largest share in 2021 due to the growing requirement for data management and workflow for clinical trial imaging
- Operational imaging services held a significant share in 2021 and include imaging modalities such as MRI, CT scan, Ultrasound, Optical Coherence Tomography (OCT), X-rays, and others
- CT Scan modality held the largest share in 2021 due to its non-invasive nature and its ability to provide detailed information about the disease for enhanced treatment
- The other application segment held the largest share in 2021. This segment includes oncology, neurology, and musculoskeletal. Market players such as ICON, Bioclinica, Navitas Life Sciences, and Paraxel International are developing their clinical trial imaging services for these applications
- CROs held the largest share in 2021 due to increasing investments in the field of research and development, snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time, and patent expiration
- North America dominated this market with the largest share in 2021 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1.Data for primary interviews in North America
1.3.5.2.Data for primary interviews in Europe
1.3.5.3.Data for primary interviews in Asia Pacific
1.3.5.4.Data for primary interviews in Latin America
1.3.5.5.Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1.Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1.Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. CLINICAL TRIAL IMAGING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1.Growing number of pharmaceutical and biotechnological companies
3.4.1.2.Growing number of Contract Research Organization
3.4.1.3. Increasing Research and Development investments ‘
3.4.2. Market restraint analysis
3.4.2.1.High cost of machineries and installations
3.5. X-ray Systems Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1.Supplier power
3.5.1.2.Buyer power
3.5.1.3.Substitution threat
3.5.1.4.Threat of new entrant
3.5.1.5.Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1.Political landscape
3.5.2.2.Technological landscape
3.5.2.3.Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. CLINICAL TRIAL IMAGING MARKET: SERVICE ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. Clinical Trial Design and Consultation Services
4.1.2. Reading and Analytical Services
4.1.3. Operational Imaging
4.1.3.1.Computed Tomography (CT) Scan
4.1.3.2.MRI (Magnetic Resonance Imaging)
4.1.3.3.X-ray
4.1.3.4.Ultrasound
4.1.3.5.Optical Coherence Tomography (OCT)
4.1.3.6.Others
4.1.4. System and Technology Support Services
4.1.5. Project and Data Management
4.2. Services Market Share, 2017 & 2030
4.3. Segment Dashboard
4.4. Global Clinical Trial Imaging Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Clinical Trial Design and Consultation Services
4.5.1.1.Clinical Trial Design and Consultation Services market estimates and forecast 2018 to 2030, (USD Million)
4.5.2. Reading and Analytical Services
4.5.2.1.Reading and Analytical Services market estimates and forecast 2018 to 2030, (USD Million)
4.5.3. Operational Imaging Services
4.5.3.1.Operational Imaging Services market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.1.Computed Tomography (CT) Scan
4.5.3.1.1.1.Computed Tomography (CT) Scan market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.2.Magnetic Resonance Imaging (MRI)
4.5.3.1.2.1.Magnetic Resonance Imaging (MRI) Scan market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.3.X-rays
4.5.3.1.3.1.X-rays Scan market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.4.Ultrasound
4.5.3.1.4.1.Ultrasound market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.5.Optical Coherence Tomography (OCT)
4.5.3.1.5.1.Optical Coherence Tomography (OCT) market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.6.Others
4.5.3.1.6.1.Others market estimates and forecast 2018 to 2030, (USD Million)
4.5.4. System and Technology Support Services
4.5.4.1.System and Technology Support Services market estimates and forecast 2018 to 2030, (USD Million)
4.5.5. Project and Data Management
4.5.5.1.Project and Data Management market estimates and forecast 2018 to 2030, (USD Million)
CHAPTER 5. CLINICAL TRIAL IMAGING MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Nonalcoholic Steatohepatitis (NASH)
5.1.2. Chronic Kidney Disease (CKD)
5.1.3. Diabetes
5.1.4. Cardiovascular Diseases
5.1.5. Ophthalmology
5.1.6. Musculoskeletal
5.1.7. Oncology
5.1.8. Gastroenterology
5.1.9. Pediatrics
5.1.10. Others
5.2. Application Market Share, 2017 & 2030
5.3. Segment Dashboard
5.4. Clinical Trial Imaging Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Nonalcoholic Steatohepatitis (NASH)
5.5.1.1.Nonalcoholic Steatohepatitis estimates and forecast 2018 to 2030, (USD Million)
5.5.2. Chronic Kidney Disease
5.5.2.1.Chronic Kidney Disease estimates and forecast 2018 to 2030, (USD Million)
5.5.3. Diabetes
5.5.3.1.Diabetes market estimates and forecast 2018 to 2030, (USD Million)
5.5.4. Cardiovascular Diseases
5.5.4.1.Cardiovascular Diseases market estimates and forecast 2018 to 2030, (USD Million)
5.5.5. Ophthalmology
5.5.5.1.Ophthalmology market estimates and forecast 2018 to 2030, (USD Million)
5.5.6. Oncology
5.5.6.1.Oncology Diseases market estimates and forecast 2018 to 2030, (USD Million)
5.5.7. Musculoskeletal
5.5.7.1.Musculoskeletal market estimates and forecast 2018 to 2030, (USD Million)
5.5.8. Gastroenterology
5.5.8.1.Gastroenterology market estimates and forecast 2018 to 2030, (USD Million)
5.5.9. Pediatrics
5.5.9.1.Pediatrics market estimates and forecast 2018 to 2030, (USD Million)
5.5.10. Others
5.5.10.1.Others market estimates and forecast 2018 to 2030, (USD Million)
CHAPTER 6. CLINICAL TRIAL IMAGING MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Definitions and Scope
6.1.1. Biotechnology and Pharmaceutical Companies
6.1.2. Medical Devices Manufacturers
6.1.3. Academic and Government Research Institutes
6.1.4. Contract Research Organization (CRO)
6.1.5. Others (Cosmetics and skin care industries)
6.2. End Use Market Share, 2017 & 2030
6.3. Segment Dashboard
6.4. Clinical Trial Imaging Market by End Use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Biotechnology and Pharmaceutical Companies
6.5.1.1.Biotechnology and Pharmaceutical Companies estimates and forecast 2018 to 2030, (USD Million)
6.5.2. Medical Devices Manufacturers
6.5.2.1.Medical Devices Manufacturers estimates and forecast 2018 to 2030, (USD Million)
6.5.3. Academic and Government Research Institutes
6.5.3.1.Academic and Government Research Institutes market estimates and forecast 2018 to 2030, (USD Million)
6.5.4. Contract Research Organization (CRO)
6.5.4.1.Contract Research Organization (CRO) market estimates and forecast 2018 to 2030, (USD Million)
6.5.5. Others
6.5.5.1.Others market estimates and forecast 2018 to 2030, (USD Million)
CHAPTER 7. CLINICAL TRIAL IMAGING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional market share analysis, 2017 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2017
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.7.2. U.S.
7.7.2.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.7.3. Canada
7.7.3.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.8. Europe
7.8.1. U.K.
7.8.1.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.8.2. Germany
7.8.2.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.8.3. France
7.8.3.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.8.4. Italy
7.8.4.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.8.5. Spain
7.8.5.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.9.1. Japan
7.9.1.1.Market estimates and forecast, 2017 - 2030 (Volume, Thousand)
7.9.2. China
7.9.2.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.9.3. India
7.9.3.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.9.4. Thailand
7.9.4.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.9.5. South Korea
7.9.5.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.10. Latin America
7.10.1. Brazil
7.10.1.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.10.2. Mexico
7.10.2.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.10.3. Argentina
7.10.3.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.10.4. Colombia
7.10.4.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.11.2. South Africa
7.11.2.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.11.3. UAE
7.11.3.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2017
8.3.4. IXICO plc
8.3.4.1.Company overview
8.3.4.2.Financial performance
8.3.4.3.Modality benchmarking
8.3.4.4.Strategic initiatives
8.3.5. Navitas Life Sciences
8.3.5.1.Company overview
8.3.5.2.Financial performance
8.3.5.3.Modality benchmarking
8.3.5.4.Strategic initiatives
8.3.6. Resonance Health
8.3.6.1.Company overview
8.3.6.2.Financial performance
8.3.6.3.Modality benchmarking
8.3.6.4.Strategic initiatives
8.3.7. ProScan Imaging
8.3.7.1.Company overview
8.3.7.2.Financial performance
8.3.7.3.Modality benchmarking
8.3.7.4.Strategic initiatives
8.3.8. Radiant Sage LLC
8.3.8.1.Company overview
8.3.8.2.Financial performance
8.3.8.3.Modality benchmarking
8.3.8.4.Strategic initiatives
8.3.9. Medpace
8.3.9.1.Company overview
8.3.9.2.Financial performance
8.3.9.3.Modality benchmarking
8.3.9.4.Strategic initiatives
8.3.10. Biomedical Systems Corp.
8.3.10.1.Company overview
8.3.10.2.Financial performance
8.3.10.3.Modality benchmarking
8.3.10.4.Strategic initiatives
8.3.11. Cardiovascular Imaging Technologies
8.3.11.1.Company overview
8.3.11.2. Financial performance
8.3.11.3. Modality benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Intrinsic Imaging
8.3.12.1. Company overview
8.3.12.2.Financial performance
8.3.12.3.Modality benchmarking
8.3.12.4.Strategic initiatives
8.3.13. BioTelemetry
8.3.13.1.Company overview
8.3.13.2.Financial performance
8.3.13.3.Modality benchmarking
8.3.13.4.Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1.Data for primary interviews in North America
1.3.5.2.Data for primary interviews in Europe
1.3.5.3.Data for primary interviews in Asia Pacific
1.3.5.4.Data for primary interviews in Latin America
1.3.5.5.Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1.Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1.Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. CLINICAL TRIAL IMAGING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1.Growing number of pharmaceutical and biotechnological companies
3.4.1.2.Growing number of Contract Research Organization
3.4.1.3. Increasing Research and Development investments ‘
3.4.2. Market restraint analysis
3.4.2.1.High cost of machineries and installations
3.5. X-ray Systems Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1.Supplier power
3.5.1.2.Buyer power
3.5.1.3.Substitution threat
3.5.1.4.Threat of new entrant
3.5.1.5.Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1.Political landscape
3.5.2.2.Technological landscape
3.5.2.3.Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. CLINICAL TRIAL IMAGING MARKET: SERVICE ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. Clinical Trial Design and Consultation Services
4.1.2. Reading and Analytical Services
4.1.3. Operational Imaging
4.1.3.1.Computed Tomography (CT) Scan
4.1.3.2.MRI (Magnetic Resonance Imaging)
4.1.3.3.X-ray
4.1.3.4.Ultrasound
4.1.3.5.Optical Coherence Tomography (OCT)
4.1.3.6.Others
4.1.4. System and Technology Support Services
4.1.5. Project and Data Management
4.2. Services Market Share, 2017 & 2030
4.3. Segment Dashboard
4.4. Global Clinical Trial Imaging Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Clinical Trial Design and Consultation Services
4.5.1.1.Clinical Trial Design and Consultation Services market estimates and forecast 2018 to 2030, (USD Million)
4.5.2. Reading and Analytical Services
4.5.2.1.Reading and Analytical Services market estimates and forecast 2018 to 2030, (USD Million)
4.5.3. Operational Imaging Services
4.5.3.1.Operational Imaging Services market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.1.Computed Tomography (CT) Scan
4.5.3.1.1.1.Computed Tomography (CT) Scan market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.2.Magnetic Resonance Imaging (MRI)
4.5.3.1.2.1.Magnetic Resonance Imaging (MRI) Scan market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.3.X-rays
4.5.3.1.3.1.X-rays Scan market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.4.Ultrasound
4.5.3.1.4.1.Ultrasound market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.5.Optical Coherence Tomography (OCT)
4.5.3.1.5.1.Optical Coherence Tomography (OCT) market estimates and forecast 2018 to 2030, (USD Million)
4.5.3.1.6.Others
4.5.3.1.6.1.Others market estimates and forecast 2018 to 2030, (USD Million)
4.5.4. System and Technology Support Services
4.5.4.1.System and Technology Support Services market estimates and forecast 2018 to 2030, (USD Million)
4.5.5. Project and Data Management
4.5.5.1.Project and Data Management market estimates and forecast 2018 to 2030, (USD Million)
CHAPTER 5. CLINICAL TRIAL IMAGING MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Nonalcoholic Steatohepatitis (NASH)
5.1.2. Chronic Kidney Disease (CKD)
5.1.3. Diabetes
5.1.4. Cardiovascular Diseases
5.1.5. Ophthalmology
5.1.6. Musculoskeletal
5.1.7. Oncology
5.1.8. Gastroenterology
5.1.9. Pediatrics
5.1.10. Others
5.2. Application Market Share, 2017 & 2030
5.3. Segment Dashboard
5.4. Clinical Trial Imaging Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Nonalcoholic Steatohepatitis (NASH)
5.5.1.1.Nonalcoholic Steatohepatitis estimates and forecast 2018 to 2030, (USD Million)
5.5.2. Chronic Kidney Disease
5.5.2.1.Chronic Kidney Disease estimates and forecast 2018 to 2030, (USD Million)
5.5.3. Diabetes
5.5.3.1.Diabetes market estimates and forecast 2018 to 2030, (USD Million)
5.5.4. Cardiovascular Diseases
5.5.4.1.Cardiovascular Diseases market estimates and forecast 2018 to 2030, (USD Million)
5.5.5. Ophthalmology
5.5.5.1.Ophthalmology market estimates and forecast 2018 to 2030, (USD Million)
5.5.6. Oncology
5.5.6.1.Oncology Diseases market estimates and forecast 2018 to 2030, (USD Million)
5.5.7. Musculoskeletal
5.5.7.1.Musculoskeletal market estimates and forecast 2018 to 2030, (USD Million)
5.5.8. Gastroenterology
5.5.8.1.Gastroenterology market estimates and forecast 2018 to 2030, (USD Million)
5.5.9. Pediatrics
5.5.9.1.Pediatrics market estimates and forecast 2018 to 2030, (USD Million)
5.5.10. Others
5.5.10.1.Others market estimates and forecast 2018 to 2030, (USD Million)
CHAPTER 6. CLINICAL TRIAL IMAGING MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Definitions and Scope
6.1.1. Biotechnology and Pharmaceutical Companies
6.1.2. Medical Devices Manufacturers
6.1.3. Academic and Government Research Institutes
6.1.4. Contract Research Organization (CRO)
6.1.5. Others (Cosmetics and skin care industries)
6.2. End Use Market Share, 2017 & 2030
6.3. Segment Dashboard
6.4. Clinical Trial Imaging Market by End Use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Biotechnology and Pharmaceutical Companies
6.5.1.1.Biotechnology and Pharmaceutical Companies estimates and forecast 2018 to 2030, (USD Million)
6.5.2. Medical Devices Manufacturers
6.5.2.1.Medical Devices Manufacturers estimates and forecast 2018 to 2030, (USD Million)
6.5.3. Academic and Government Research Institutes
6.5.3.1.Academic and Government Research Institutes market estimates and forecast 2018 to 2030, (USD Million)
6.5.4. Contract Research Organization (CRO)
6.5.4.1.Contract Research Organization (CRO) market estimates and forecast 2018 to 2030, (USD Million)
6.5.5. Others
6.5.5.1.Others market estimates and forecast 2018 to 2030, (USD Million)
CHAPTER 7. CLINICAL TRIAL IMAGING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional market share analysis, 2017 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2017
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.7.2. U.S.
7.7.2.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.7.3. Canada
7.7.3.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.8. Europe
7.8.1. U.K.
7.8.1.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.8.2. Germany
7.8.2.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.8.3. France
7.8.3.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.8.4. Italy
7.8.4.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.8.5. Spain
7.8.5.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.9.1. Japan
7.9.1.1.Market estimates and forecast, 2017 - 2030 (Volume, Thousand)
7.9.2. China
7.9.2.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.9.3. India
7.9.3.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.9.4. Thailand
7.9.4.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.9.5. South Korea
7.9.5.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.10. Latin America
7.10.1. Brazil
7.10.1.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.10.2. Mexico
7.10.2.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.10.3. Argentina
7.10.3.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.10.4. Colombia
7.10.4.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.11.2. South Africa
7.11.2.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
7.11.3. UAE
7.11.3.1.Market estimates and forecast, 2017 - 2030 (Value & Volume)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2017
8.3.4. IXICO plc
8.3.4.1.Company overview
8.3.4.2.Financial performance
8.3.4.3.Modality benchmarking
8.3.4.4.Strategic initiatives
8.3.5. Navitas Life Sciences
8.3.5.1.Company overview
8.3.5.2.Financial performance
8.3.5.3.Modality benchmarking
8.3.5.4.Strategic initiatives
8.3.6. Resonance Health
8.3.6.1.Company overview
8.3.6.2.Financial performance
8.3.6.3.Modality benchmarking
8.3.6.4.Strategic initiatives
8.3.7. ProScan Imaging
8.3.7.1.Company overview
8.3.7.2.Financial performance
8.3.7.3.Modality benchmarking
8.3.7.4.Strategic initiatives
8.3.8. Radiant Sage LLC
8.3.8.1.Company overview
8.3.8.2.Financial performance
8.3.8.3.Modality benchmarking
8.3.8.4.Strategic initiatives
8.3.9. Medpace
8.3.9.1.Company overview
8.3.9.2.Financial performance
8.3.9.3.Modality benchmarking
8.3.9.4.Strategic initiatives
8.3.10. Biomedical Systems Corp.
8.3.10.1.Company overview
8.3.10.2.Financial performance
8.3.10.3.Modality benchmarking
8.3.10.4.Strategic initiatives
8.3.11. Cardiovascular Imaging Technologies
8.3.11.1.Company overview
8.3.11.2. Financial performance
8.3.11.3. Modality benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Intrinsic Imaging
8.3.12.1. Company overview
8.3.12.2.Financial performance
8.3.12.3.Modality benchmarking
8.3.12.4.Strategic initiatives
8.3.13. BioTelemetry
8.3.13.1.Company overview
8.3.13.2.Financial performance
8.3.13.3.Modality benchmarking
8.3.13.4.Strategic initiatives
LIST OF TABLES
Table 1 List of Abbreviation
Table 2 North America clinical trial imaging devices market, by region, 2018 - 2030 (USD Million)
Table 3 North America clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 4 North America clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 5 North America clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 7 U.S. clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 10 Canada clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 11 Canada clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe clinical trial imaging devices market, by region (USD Million) 2018 -2030
Table 13 Europe clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 14 Europe clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 15 Europe clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 16 Germany clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 17 Germany clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 18 Germany clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 19 U.K. clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 20 U.K. clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 21 U.K. clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 22 France clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 23 France clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 24 France clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 26 Italy clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 27 Italy clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 29 Spain clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 30 Spain clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 31 APAC clinical trial imaging devices market, by region, 2018 - 2030 (USD Million)
Table 32 APAC clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 33 APAC clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 34 APAC clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 35 China clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 36 China clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 37 China clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 38 Japan clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 39 Japan clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 40 Japan clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 41 India clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 42 India clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 43 India clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 44 Thailand clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 45 Thailand clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 46 Thailand clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 47 South Korea clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 48 South Korea clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 49 South Korea clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 50 Latin America clinical trial imaging devices market, by region, 2018 - 2030 (USD Million)
Table 51 Latin America clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 52 Latin America clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 53 Latin America clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 54 Brazil clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 55 Brazil clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 56 Brazil clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 57 Mexico clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 58 Mexico clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 59 Mexico clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 60 Argentina clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 61 Argentina clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 62 Argentina clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 63 Colombia clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 64 Colombia clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 65 Colombia clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 66 Middle East and Africa clinical trial imaging devices market, by region, 2018 - 2030 (USD Million)
Table 67 Middle East and Africa clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 68 Middle East and Africa clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 69 Middle East and Africa clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 70 South Africa clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 71 South Africa clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 72 South Africa clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 75 Saudi Arabia clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 76 UAE clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 77 UAE clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 78 UAE clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of Abbreviation
Table 2 North America clinical trial imaging devices market, by region, 2018 - 2030 (USD Million)
Table 3 North America clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 4 North America clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 5 North America clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 7 U.S. clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 10 Canada clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 11 Canada clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe clinical trial imaging devices market, by region (USD Million) 2018 -2030
Table 13 Europe clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 14 Europe clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 15 Europe clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 16 Germany clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 17 Germany clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 18 Germany clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 19 U.K. clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 20 U.K. clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 21 U.K. clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 22 France clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 23 France clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 24 France clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 26 Italy clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 27 Italy clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 29 Spain clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 30 Spain clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 31 APAC clinical trial imaging devices market, by region, 2018 - 2030 (USD Million)
Table 32 APAC clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 33 APAC clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 34 APAC clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 35 China clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 36 China clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 37 China clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 38 Japan clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 39 Japan clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 40 Japan clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 41 India clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 42 India clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 43 India clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 44 Thailand clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 45 Thailand clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 46 Thailand clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 47 South Korea clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 48 South Korea clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 49 South Korea clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 50 Latin America clinical trial imaging devices market, by region, 2018 - 2030 (USD Million)
Table 51 Latin America clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 52 Latin America clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 53 Latin America clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 54 Brazil clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 55 Brazil clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 56 Brazil clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 57 Mexico clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 58 Mexico clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 59 Mexico clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 60 Argentina clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 61 Argentina clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 62 Argentina clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 63 Colombia clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 64 Colombia clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 65 Colombia clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 66 Middle East and Africa clinical trial imaging devices market, by region, 2018 - 2030 (USD Million)
Table 67 Middle East and Africa clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 68 Middle East and Africa clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 69 Middle East and Africa clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 70 South Africa clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 71 South Africa clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 72 South Africa clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 75 Saudi Arabia clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
Table 76 UAE clinical trial imaging devices market, by service, 2018 - 2030 (USD Million)
Table 77 UAE clinical trial imaging devices market, by application, 2018 - 2030 (USD Million)
Table 78 UAE clinical trial imaging devices market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Clinical trial imaging: market outlook
Fig. 14 Clinical trial imaging market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Clinical trial imaging market driver impact
Fig. 20 Clinical trial imaging market restraint impact
Fig. 21 Clinical trial imaging market strategic initiatives analysis
Fig. 22 Clinical trial imaging market: service movement analysis
Fig. 23 Clinical trial imaging market: service outlook and key takeaways
Fig. 24 Clinical trial design and consultation services market estimates and forecast, 2018 - 2030
Fig. 25 Reading and analytical services market estimates and forecast, 2018 - 2030
Fig. 26 Operational Imaging services market estimates and forecast, 2018 - 2030
Fig. 27 Computed Tomography (CT) Scan market estimates and forecast, 2018 - 2030
Fig. 28 MRI (Magnetic Resonance Imaging) market estimates and forecast, 2018 - 2030
Fig. 29 X-Ray market estimates and forecast, 2018 - 2030
Fig. 30 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 31 Optical Coherence Tomography (OCT) market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 System and technology support services market estimates and forecast, 2018 - 2030
Fig. 34 Project and data management market estimates and forecast, 2018 - 2030
Fig. 35 Clinical trial imaging market: application movement analysis
Fig. 36 Clinical trial imaging market: application outlook and key takeaways
Fig. 37 NASH market estimates and forecast, 2018 - 2030
Fig. 38 CKD estimates and forecast, 2018 - 2030
Fig. 39 Diabetes estimates and forecast, 2018 - 2030
Fig. 40 Cardiovascular diseases estimates and forecast, 2018 - 2030
Fig. 41 Ophthalmology market estimates and forecast, 2018 - 2030
Fig. 42 Musculoskeletal estimates and forecast, 2018 - 2030
Fig. 43 Oncology estimates and forecast, 2018 - 2030
Fig. 44 Gastroenterology diseases estimates and forecast, 2018 - 2030
Fig. 45 Pediatrics diseases estimates and forecast, 2018 - 2030
Fig. 46 Others estimates and forecast, 2018 - 2030
Fig. 47 Clinical trial imaging market: end-use movement analysis
Fig. 48 Clinical trial imaging market: end use outlook and key takeaways
Fig. 49 Biotechnology and pharmaceutical companies estimate and forecast, 2018 - 2030
Fig. 50 Medical devices manufacturers estimates and forecast, 2018 - 2030
Fig. 51 Academic and government research institutes estimates and forecast, 2018 - 2030
Fig. 52 Contract Research Organization (CROs) estimates and forecast, 2018 - 2030
Fig. 53 Others estimates and forecast, 2018 - 2030
Fig. 54 Global clinical trial imaging market: regional movement analysis
Fig. 55 Global clinical trial imaging market: regional outlook and key takeaways
Fig. 56 Global market share and leading players
Fig. 57 North America market share and leading players
Fig. 58 Europe market share and leading players
Fig. 59 Asia Pacific market share and leading players
Fig. 60 Latin America market share and leading players
Fig. 61 Middle East & Africa market share and leading players
Fig. 62 North America: SWOT
Fig. 63 Europe SWOT
Fig. 64 Asia Pacific SWOT
Fig. 65 Latin America SWOT
Fig. 66 MEA SWOT
Fig. 67 North America, by country
Fig. 68 North America
Fig. 69 North America market estimates and forecast, 2018 - 2030
Fig. 70 U. S.
Fig. 71 U. S. market estimates and forecast, 2018 - 2030
Fig. 72 Canada
Fig. 73 Canada market estimates and forecast, 2018 - 2030
Fig. 74 Europe
Fig. 75 Europe. market estimates and forecast, 2018 - 2030
Fig. 76 U. K.
Fig. 77 U. K. market estimates and forecast, 2018 - 2030
Fig. 78 Germany
Fig. 79 Germany market estimates and forecast, 2018 - 2030
Fig. 80 France
Fig. 81 France market estimates and forecast, 2018 - 2030
Fig. 82 Italy
Fig. 83 Italy market estimates and forecast, 2018 - 2030
Fig. 84 Spain
Fig. 85 Spain market estimates and forecast, 2018 - 2030
Fig. 86 Asia Pacific
Fig. 87 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 88 China
Fig. 89 China market estimates and forecast, 2018 - 2030
Fig. 90 Japan
Fig. 91 Japan market estimates and forecast, 2018 - 2030
Fig. 92 India
Fig. 93 India market estimates and forecast, 2018 - 2030
Fig. 94 Thailand
Fig. 95 Thailand. market estimates and forecast, 2018 - 2030
Fig. 96 South Korea
Fig. 97 South Korea market estimates and forecast, 2018 - 2030
Fig. 98 Latin America
Fig. 99 Latin America market estimates and forecast, 2018 - 2030
Fig. 100 Brazil
Fig. 101 Brazil market estimates and forecast, 2018 - 2030
Fig. 102 Mexico
Fig. 103 Mexico market estimates and forecast, 2018 - 2030
Fig. 104 Argentina
Fig. 105 Argentina market estimates and forecast, 2018 - 2030
Fig. 106 Colombia
Fig. 107 Colombia market estimates and forecast, 2018 - 2030
Fig. 108 Middle East and Africa
Fig. 109 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 110 South Africa
Fig. 111 South Africa market estimates and forecast, 2018 - 2030
Fig. 112 Saudi Arabia
Fig. 113 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 114 UAE
Fig. 115 UAE market estimates and forecast, 2018 - 2030
Fig. 116 Participant categorization- clinical trial imaging market
Fig. 117 Market share of key market players- clinical trial imaging market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Clinical trial imaging: market outlook
Fig. 14 Clinical trial imaging market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Clinical trial imaging market driver impact
Fig. 20 Clinical trial imaging market restraint impact
Fig. 21 Clinical trial imaging market strategic initiatives analysis
Fig. 22 Clinical trial imaging market: service movement analysis
Fig. 23 Clinical trial imaging market: service outlook and key takeaways
Fig. 24 Clinical trial design and consultation services market estimates and forecast, 2018 - 2030
Fig. 25 Reading and analytical services market estimates and forecast, 2018 - 2030
Fig. 26 Operational Imaging services market estimates and forecast, 2018 - 2030
Fig. 27 Computed Tomography (CT) Scan market estimates and forecast, 2018 - 2030
Fig. 28 MRI (Magnetic Resonance Imaging) market estimates and forecast, 2018 - 2030
Fig. 29 X-Ray market estimates and forecast, 2018 - 2030
Fig. 30 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 31 Optical Coherence Tomography (OCT) market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 System and technology support services market estimates and forecast, 2018 - 2030
Fig. 34 Project and data management market estimates and forecast, 2018 - 2030
Fig. 35 Clinical trial imaging market: application movement analysis
Fig. 36 Clinical trial imaging market: application outlook and key takeaways
Fig. 37 NASH market estimates and forecast, 2018 - 2030
Fig. 38 CKD estimates and forecast, 2018 - 2030
Fig. 39 Diabetes estimates and forecast, 2018 - 2030
Fig. 40 Cardiovascular diseases estimates and forecast, 2018 - 2030
Fig. 41 Ophthalmology market estimates and forecast, 2018 - 2030
Fig. 42 Musculoskeletal estimates and forecast, 2018 - 2030
Fig. 43 Oncology estimates and forecast, 2018 - 2030
Fig. 44 Gastroenterology diseases estimates and forecast, 2018 - 2030
Fig. 45 Pediatrics diseases estimates and forecast, 2018 - 2030
Fig. 46 Others estimates and forecast, 2018 - 2030
Fig. 47 Clinical trial imaging market: end-use movement analysis
Fig. 48 Clinical trial imaging market: end use outlook and key takeaways
Fig. 49 Biotechnology and pharmaceutical companies estimate and forecast, 2018 - 2030
Fig. 50 Medical devices manufacturers estimates and forecast, 2018 - 2030
Fig. 51 Academic and government research institutes estimates and forecast, 2018 - 2030
Fig. 52 Contract Research Organization (CROs) estimates and forecast, 2018 - 2030
Fig. 53 Others estimates and forecast, 2018 - 2030
Fig. 54 Global clinical trial imaging market: regional movement analysis
Fig. 55 Global clinical trial imaging market: regional outlook and key takeaways
Fig. 56 Global market share and leading players
Fig. 57 North America market share and leading players
Fig. 58 Europe market share and leading players
Fig. 59 Asia Pacific market share and leading players
Fig. 60 Latin America market share and leading players
Fig. 61 Middle East & Africa market share and leading players
Fig. 62 North America: SWOT
Fig. 63 Europe SWOT
Fig. 64 Asia Pacific SWOT
Fig. 65 Latin America SWOT
Fig. 66 MEA SWOT
Fig. 67 North America, by country
Fig. 68 North America
Fig. 69 North America market estimates and forecast, 2018 - 2030
Fig. 70 U. S.
Fig. 71 U. S. market estimates and forecast, 2018 - 2030
Fig. 72 Canada
Fig. 73 Canada market estimates and forecast, 2018 - 2030
Fig. 74 Europe
Fig. 75 Europe. market estimates and forecast, 2018 - 2030
Fig. 76 U. K.
Fig. 77 U. K. market estimates and forecast, 2018 - 2030
Fig. 78 Germany
Fig. 79 Germany market estimates and forecast, 2018 - 2030
Fig. 80 France
Fig. 81 France market estimates and forecast, 2018 - 2030
Fig. 82 Italy
Fig. 83 Italy market estimates and forecast, 2018 - 2030
Fig. 84 Spain
Fig. 85 Spain market estimates and forecast, 2018 - 2030
Fig. 86 Asia Pacific
Fig. 87 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 88 China
Fig. 89 China market estimates and forecast, 2018 - 2030
Fig. 90 Japan
Fig. 91 Japan market estimates and forecast, 2018 - 2030
Fig. 92 India
Fig. 93 India market estimates and forecast, 2018 - 2030
Fig. 94 Thailand
Fig. 95 Thailand. market estimates and forecast, 2018 - 2030
Fig. 96 South Korea
Fig. 97 South Korea market estimates and forecast, 2018 - 2030
Fig. 98 Latin America
Fig. 99 Latin America market estimates and forecast, 2018 - 2030
Fig. 100 Brazil
Fig. 101 Brazil market estimates and forecast, 2018 - 2030
Fig. 102 Mexico
Fig. 103 Mexico market estimates and forecast, 2018 - 2030
Fig. 104 Argentina
Fig. 105 Argentina market estimates and forecast, 2018 - 2030
Fig. 106 Colombia
Fig. 107 Colombia market estimates and forecast, 2018 - 2030
Fig. 108 Middle East and Africa
Fig. 109 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 110 South Africa
Fig. 111 South Africa market estimates and forecast, 2018 - 2030
Fig. 112 Saudi Arabia
Fig. 113 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 114 UAE
Fig. 115 UAE market estimates and forecast, 2018 - 2030
Fig. 116 Participant categorization- clinical trial imaging market
Fig. 117 Market share of key market players- clinical trial imaging market
